Skip to main content
OpenTrials

Clinical trial condition

Moderate to Severe Plaque Psoriasis

Explore clinical trials studying Moderate to Severe Plaque Psoriasis. Study availability and eligibility vary by location and protocol.

35 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Moderate to Severe Plaque Psoriasis trial results

Completed

A Study to Assess the Pharmacokinetics, Safety, and Efficacy of Two Doses of Bimekizumab in Adolescent Study Participants With Moderate to Severe Plaque Psoriasis

NCT04718896

Conditions
Moderate to Severe Plaque Psoriasis, Psoriasis, Skin Diseases, +2 more
Locations
  • Ps0020 50344 Indianapolis, Indiana, United States
  • Ps0020 50359 Cypress, Texas, United States
  • Ps0020 50354 Calgary, Canada
  • Ps0020 50357 St. John's, Canada
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT03412747

Conditions
Chronic Plaque Psoriasis, Moderate to Severe Plaque Psoriasis, Psoriasis, +3 more
Locations
  • Ps0008 957 Glendale, Arizona, United States
  • Ps0008 927 Los Angeles, California, United States
  • Ps0008 955 San Diego, California, United States
  • Ps0008 943 San Luis Obispo, California, United States
View all 77 locations
View Trial Details
Completed

To Assess the Effect of SCD-044 Treatment on Moderate to Severe Plaque Psoriasis

NCT04566666

Conditions
Moderate to Severe Plaque Psoriasis
Locations
  • Yuma Clinical Trials, LLC Yuma, Arizona, United States
  • T. Joseph Raoof Md, Imc./Encino Research Center Encino, California, United States
  • Metropolis Dermatology Los Angeles, California, United States
  • Axis Clinical Trials Los Angeles, California, United States
View all 50 locations
View Trial Details
Completed

2 Years Prospective Study to Collect Real-life Data on the Retention, Quality of Life, Effectiveness and Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis

NCT05155098

Conditions
Ankylosing Spondylitis, Ankylosis, Arthritis, +18 more
Locations
  • Novartis Investigative Site Songkhla, Hat Yai, Thailand
  • Novartis Investigative Site Muang, Thailand
  • Novartis Investigative Site Khon Kaen, THA, Thailand
  • Novartis Investigative Site Bangkok, Thailand
View Trial Details
Completed

A Study to Compare SB17 (Proposed Ustekinumab Biosimilar) to Stelara® in Subject With Moderate to Severe Plaque Psoriasis

NCT04967508

Conditions
Moderate to Severe Plaque Psoriasis, Psoriasis, Skin Diseases, +2 more
Locations
  • SB Investigative Site Brno, Czechia
  • SB Investigative Site Ostrava, Czechia
  • SB Investigative Site Pardubice, Czechia
  • SB Investigative Site Prague, Czechia
View all 32 locations
View Trial Details
Completed

Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ICP-488 in Patients with Moderate to Severe Plaque Psoriasis

NCT06109818

Conditions
Moderate to Severe Plaque Psoriasis
Locations
  • Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • China-Japan Friendship Hospital Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
  • The First Affiliated Hospital of Fujian Medical University Fuzhou, Fujian, China
View all 31 locations
View Trial Details

Related conditions